Latest Period
Q1 2026
Security Snapshot
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) Institutional Ownership
CUSIP: 19243B102
13F Institutional Holders and Ownership History from Q4 2021 to Q1 2026
Institutions Reporting
74
Shares (Excl. Options)
21,406,784
Price
$0.76
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Symbol
- CGTX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 21,406,784
- Total 13F value
- $16,261,960
- Portfolio coverage rank
- 0%
- Share change
- -177,173
- Value change
- -$482,537
- Number of holders
- 74
- Shares outstanding
- 87,819,638
- SEC-reported price per share
- $1.28
- Insider filing price
- $1.28
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share is tracked under CUSIP 19243B102.
- 74 institutions reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 79 to 74 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $28,929,187 to $16,261,960.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 74 institutions filings for Q1 2026.
Security key
19243B102
Latest holder period
Q1 2026
13F holders
74
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
CGTX full holder history
COGNITION THERAPEUTICS INC SEC filings
COGNITION THERAPEUTICS INC company facts
COGNITION THERAPEUTICS INC insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 19243B102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
CGTX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIOS Memory SPV I, LP | 6.9% | $15,027,696 | 6,059,555 | AARON G.L. FLETCHER | 19 Sep 2025 |
As of 31 Mar 2026, 74 institutional investors reported holding 21,406,784 shares of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX). This represents 24% of the company’s total 87,819,638 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
23%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BIOS Capital Management, LP | 6.8% | 6,000,000 | 0% | 8.6% | $4,560,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.4% | 3,001,787 | 0% | 0% | $2,281,358 |
| DAVENPORT & Co LLC | 3.3% | 2,892,808 | +0.73% | 0.01% | $2,197,088 |
| RENAISSANCE TECHNOLOGIES LLC | 1.3% | 1,117,136 | +15% | 0% | $848,465 |
| Chescapmanager LLC | 1.1% | 997,029 | 0% | 0.12% | $757,244 |
| BlackRock, Inc. | 1.1% | 968,362 | -4.5% | 0% | $735,472 |
| GEODE CAPITAL MANAGEMENT, LLC | 1% | 920,208 | +5.3% | 0% | $699,234 |
| Hilton Capital Management, LLC | 0.63% | 548,950 | 0% | 0.03% | $416,928 |
| VANGUARD FIDUCIARY TRUST CO | 0.53% | 463,684 | 0% | 0% | $352,400 |
| Dauntless Investment Group, LLC | 0.49% | 431,000 | -7.5% | 0.92% | $327,345 |
| CM Management, LLC | 0.46% | 400,000 | +100% | 0.25% | $303,800 |
| JANE STREET GROUP, LLC | 0.42% | 370,140 | -40% | 0% | $281,121 |
| Sigma Planning Corp | 0.38% | 337,765 | +56% | 0.01% | $256,533 |
| STATE STREET CORP | 0.36% | 314,483 | 0% | 0% | $238,850 |
| AMERICAN FINANCIAL GROUP INC | 0.23% | 205,000 | 0% | 0.06% | $155,698 |
| Voss Capital, LP | 0.23% | 200,000 | -28% | 0.01% | $151,900 |
| XTX Topco Ltd | 0.22% | 195,803 | +426% | 0% | $148,712 |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 0.22% | 195,000 | +1.3% | 0% | $148,103 |
| NORTHERN TRUST CORP | 0.19% | 168,686 | -13% | 0% | $128,117 |
| HRT FINANCIAL LP | 0.17% | 152,999 | 0% | $116,000 | |
| Texas Capital Bank Wealth Management Services Inc | 0.14% | 123,296 | 0% | 0.01% | $93,643 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.1% | 84,940 | 0% | 0% | $64,512 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.09% | 80,663 | +0.84% | 0% | $61,264 |
| UBS Group AG | 0.09% | 76,873 | +3.4% | 0% | $58,347 |
| Corient Private Wealth LLC | 0.08% | 72,112 | 0% | 0% | $54,769 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
18
Latest
Q1 2026
Rows shown
1-18 of 18
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 21,406,784 | $16,261,960 | -$482,537 | $0.76 | 74 |
| 2025 Q4 | 21,425,389 | $28,929,187 | +$212,111 | $1.35 | 79 |
| 2025 Q3 | 21,268,922 | $28,723,974 | +$14,962,053 | $1.35 | 68 |
| 2025 Q2 | 11,168,930 | $3,463,844 | -$159,050 | $0.31 | 45 |
| 2025 Q1 | 11,627,581 | $4,889,933 | +$37,435 | $0.42 | 48 |
| 2024 Q4 | 11,088,340 | $7,775,058 | +$595,627 | $0.70 | 44 |
| 2024 Q3 | 4,253,980 | $1,990,924 | -$2,451,158 | $0.47 | 39 |
| 2024 Q2 | 5,310,353 | $8,815,784 | -$2,998,367 | $1.66 | 46 |
| 2024 Q1 | 7,090,800 | $12,904,468 | -$197,637 | $1.82 | 46 |
| 2023 Q4 | 7,154,013 | $13,234,773 | +$56,992 | $1.85 | 36 |
| 2023 Q3 | 7,236,396 | $10,419,453 | +$193,944 | $1.44 | 34 |
| 2023 Q2 | 7,100,887 | $12,994,058 | -$80,887 | $1.83 | 34 |
| 2023 Q1 | 7,140,406 | $14,140,001 | +$282,877 | $1.98 | 32 |
| 2022 Q4 | 4,800,813 | $10,080,423 | +$4,062,100 | $2.10 | 32 |
| 2022 Q3 | 5,091,352 | $9,669,716 | +$1,037,445 | $1.90 | 29 |
| 2022 Q2 | 4,504,385 | $9,489,895 | +$5,791,733 | $2.11 | 27 |
| 2022 Q1 | 1,666,005 | $4,577,000 | +$779,768 | $2.75 | 25 |
| 2021 Q4 | 1,334,704 | $8,437,000 | +$8,437,000 | $6.32 | 18 |